Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis

A pilot study is described, in which 25 chronic CDH patients were treated with 3 MU recombinant alpha-interferon per week for 4 months. Improvement was transient and no long-term effects were noted. Side effects were well tolerated and reversible so that longer treatment and higher dosages should be...

Full description

Saved in:
Bibliographic Details
Published inArchives of virology. Supplementum Vol. 4; p. 306
Main Authors Tocci, G, Antonelli, L, Boumis, E, Colaiacomo, M, Guarascio, P, Struglia, C, Tossini, G, Visco, G
Format Journal Article
LanguageEnglish
Published Austria 1992
Subjects
Adolescent
Adult
Biopsy
Chronic Disease
Female
Hepatitis D - therapy
Humans
Interferon Type I - therapeutic use
Liver - pathology
Male
Middle Aged
Recombinant Proteins
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:A pilot study is described, in which 25 chronic CDH patients were treated with 3 MU recombinant alpha-interferon per week for 4 months. Improvement was transient and no long-term effects were noted. Side effects were well tolerated and reversible so that longer treatment and higher dosages should be possible.
ISSN:0939-1983
DOI:10.1007/978-3-7091-5633-9_69